Company Performance: Cue Health's revenue, earnings, and sales growth directly influence its stock price. Positive financial results typically lead to an increase in stock price.

FDA Regulations: Regulatory approvals or rejections of Cue Health's products significantly impact investor confidence and the stock price. Approval often drives the price up.

Market Sentiment: Overall investor mood and broader market trends, particularly within the healthcare sector, can sway CUE.US's price, regardless of company-specific news.

Competition: The emergence of new competitors or the success of existing rivals in the rapid diagnostic testing market can negatively affect Cue Health's market share and stock value.

Partnerships: Strategic collaborations or significant contracts with major healthcare providers or government entities can boost investor confidence and drive up the stock price.

Technological Advancements: Breakthrough innovations or setbacks in Cue Health's technology compared to competitors can impact the company's perceived value and stock price.

Economic Conditions: Macroeconomic factors such as inflation, interest rates, and economic growth can influence overall market sentiment and affect CUE.US's stock price.

Management Changes: Major shifts in Cue Health's leadership team can create uncertainty or confidence, impacting investor perception and the stock price.

Pandemic Trends: Fluctuations in COVID-19 cases and the demand for rapid testing can significantly influence Cue Health's revenue and stock price. Increased cases may drive up demand.